Profil
Stuart Chaffee is an Independent Director at ABG Acquisition Corp.
I.
He was previously the Chief Financial Officer at Praxis Precision Medicines, Inc. in 2020 and the Head of Business Operations at Kymera Therapeutics, Inc. from 2016 to 2017.
Dr. Chaffee holds an MBA from The Wharton School of the University of Pennsylvania.
Aktive Positionen von Stuart Chaffee
| Unternehmen | Position | Beginn |
|---|---|---|
| ABG ACQUISITION CORP. I | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Stuart Chaffee
| Unternehmen | Position | Ende |
|---|---|---|
| PRAXIS PRECISION MEDICINES, INC. | Finanzdirektor/CFO | 02.12.2020 |
| KYMERA THERAPEUTICS, INC. | Corporate Officer/Principal | 01.11.2017 |
Ausbildung von Stuart Chaffee
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops therapies for central nervous system disorders | Health Technology |
Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
ABG Acquisition Corp. I
ABG Acquisition Corp. I Financial ConglomeratesFinance Operates as a blank check company | Finance |
















